Skip Navigation



Human Molecular Genetics Advance Access published online on April 19, 2007

Human Molecular Genetics, doi:10.1093/hmg/ddm068
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
16/10/1216    most recent
ddm068v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schnichels, M.
Right arrow Articles by Willecke, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schnichels, M.
Right arrow Articles by Willecke, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The Connexin31 F137L mutant mouse as a model for the human skin disease Erythrokeratodermia variabilis (EKV)

Marc Schnichels, Philipp Wörsdörfer, Radoslaw Dobrowolski, Christian Markopoulos, Markus Kretz, Gabriele Schwarz, Elke Winterhager1 and Klaus Willecke*

Institut für Genetik, Abteilung Molekulargenetik, Universität Bonn, 53117 Bonn 1 Institut für Anatomie, Universität Duisburg-Essen, 45122 Essen

* To whom correspondence should be addressed Tel: 49 228 734210, Fax: 49 228 734263, e-mail: genetik{at}uni-bonn.de (KW)

Received October 27, 2006; Revised February 21, 2007; Accepted March 16, 2007

Erythrokeratodermia variabilis (EKV) is a rare autosomal dominant human genodermatosis. Its clinical appearance varies from transient, fast moving erythemas to persistent brown hyperkeratoses. So far, several mutations in the Cx31 or Cx30.3 gene have been reported to cause EKV in humans.

We have generated a conditional mouse mutant that carries the human F137L mutation in the Cx31 gene which was described to act in a transdominant negative manner. The phenylalanine residue at position 137 is highly conserved in several human and mouse connexin genes. Mouse embryonic stem cells expressing one allele of the Cx31F137L mutation were stable but showed about 30% decreased transfer of neurobiotin. This is probably due to dominant negative effects of the Cx31F137L protein on wild type Cx31 and Cx43 protein expressed in embryonic stem cells. Surprisingly the healing process of tail incision wounds in Cx31+/F137L mice was shortened by one day, i.e. very similar as previously reported for mice with decreased expression of Cx43 in the epidermis. This suggests again that Cx31 and Cx43 proteins functionally interact, possibly by forming heteromeric channels in the epidermis. Heterozygous Cx31+/F137L mice are viable and fertile, in contrast to homozygous Cx31F137L/F137L mice that die around ED 7.5. In Cx31+/F137L mice the epidermal expression pattern and level of Cx26, Cx30, Cx30.3 and Cx43 proteins were not altered compared to wild type mice. No erythemas were detected in young C31+/F137L mice before 2 weeks of age. In contrast to human EKV patients, hyperproliferation of the stratum germinativum was found in only 5% of the analyzed skin area.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. W. Laird
Closing the Gap on Autosomal Dominant Connexin-26 and Connexin-43 Mutants Linked to Human Disease
J. Biol. Chem., February 8, 2008; 283(6): 2997 - 3001.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.